Novel adoptive transfer mouse models in CLL
Elisa ten Hacken
AL amyloidosis and a critical, early diagnosis
What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
How do we sequence and combine novel agent-based therapies in CLL?
A targeted treatment with anti-CD19 CAR T-cells results in different responses